US Patent Issued to Jiangsu Target Biomedical Research Institute on July 7 for "Coronavirus vaccine based on controllable secretory expression of attenuated salmonella, preparation method therefor, and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,099, issued on July 7, was assigned to Jiangsu Target Biomedical Research Institute Co. Ltd. (Changzhou, China).

"Coronavirus vaccine based on controllable secretory expression of attenuated salmonella, preparation method therefor, and application thereof" was invented by Zichun Hua (Changzhou, China) and Leyang Wu (Changzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A coronavirus vaccine based on controllable secretory expression of attenuated Salmonella, a preparation method therefor, and use thereof. The method includes constructing controllable and stable expression plasmids for secretory expression of different antigenic structural d...